Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1979 Jun;7(6):551–556. doi: 10.1111/j.1365-2125.1979.tb04641.x

Quantitative assessment of bronchial beta-adrenoceptor blockade in man.

H R Gribbin, C J Baldwin, A E Tattersfield
PMCID: PMC1429682  PMID: 37867

Abstract

1. We describe a method for assessing bronchial beta-adrenoceptor blockade quantitatively in man. Specific airway conductance is measured after increasing doses of inhaled salbutamol and the extent to which the dose-response curve is displaced to the right after beta-adrenoceptor blocking drugs is used to assess bronchial beta-adrenoceptor blockade. 2. Salbutamol dose-response curves were plotted for six normal subjects by measuring sGaw 15 min after increasing doses of inhaled salbutamol. Salbutamol produced a 30-70% increase in sGaw. 3. Salbutamol dose response curves were obtained 2 h after oral practolol (100 mg and 200 mg) and oral propranolol (40 mg and 80 mg) on separate days and were displaced to the right. 4. The mean dose ratios for practolol 100 mg and 200 mg were 1.2 and 2.1 and for propranolol 40 mg and 80 mg they were 21 and 61 respectively.

Full text

PDF
551

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Benson M. K. Bronchial hyperreactivity. Br J Dis Chest. 1975 Oct;69(0):227–239. doi: 10.1016/0007-0971(75)90090-x. [DOI] [PubMed] [Google Scholar]
  2. Briant R. H., Dollery C. T., Fenyvesi T., George C. F. Assessment of selective beta-adrenoceptor blockade in man. Br J Pharmacol. 1973 Sep;49(1):106–114. doi: 10.1111/j.1476-5381.1973.tb08272.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Connolly C. K., Batten J. C. Comparison of the effect of alprenolol and propranolol on specific airway conductance in asthmatic subjects. Br Med J. 1970 May 30;2(5708):515–516. doi: 10.1136/bmj.2.5708.515. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Conolly M. E., Greenacre J. K. The beta-adrenoceptor of the human lymphocyte and human lung parenchyma. Br J Pharmacol. 1977 Jan;59(1):17–23. doi: 10.1111/j.1476-5381.1977.tb06971.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. DUBOIS A. B., BOTELHO S. Y., BEDELL G. N., MARSHALL R., COMROE J. H., Jr A rapid plethysmographic method for measuring thoracic gas volume: a comparison with a nitrogen washout method for measuring functional residual capacity in normal subjects. J Clin Invest. 1956 Mar;35(3):322–326. doi: 10.1172/JCI103281. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. DUBOIS A. B., BOTELHO S. Y., COMROE J. H., Jr A new method for measuring airway resistance in man using a body plethysmograph: values in normal subjects and in patients with respiratory disease. J Clin Invest. 1956 Mar;35(3):327–335. doi: 10.1172/JCI103282. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Daly M. J., Flook J. J., Levy G. P. The selectivity of beta-adrenoceptor antagonists on cardiovascular and bronchodilator responses to isoprenaline in the anaesthetized dog. Br J Pharmacol. 1975 Feb;53(2):173–181. doi: 10.1111/j.1476-5381.1975.tb07347.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Davies D. S. Pharmacokinetics of inhaled substances. Postgrad Med J. 1975;51(7 Suppl):69–75. [PubMed] [Google Scholar]
  9. Dunlop D., Shanks R. G. Selective blockade of adrenoceptive beta receptors in the heart. Br J Pharmacol Chemother. 1968 Jan;32(1):201–218. doi: 10.1111/j.1476-5381.1968.tb00444.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Holgate S. T., Baldwin C. J., Tattersfield A. E. beta-adrenergic agonist resistance in normal human airways. Lancet. 1977 Aug 20;2(8034):375–377. doi: 10.1016/s0140-6736(77)90304-x. [DOI] [PubMed] [Google Scholar]
  11. Kumana C. R., Kaye C. M., Leighton M., Turner P., Hamer J. Cardiac and pulmonary effects of acebutolol. Lancet. 1975 Jul 19;2(7925):89–93. doi: 10.1016/s0140-6736(75)90001-x. [DOI] [PubMed] [Google Scholar]
  12. Kumana C. R., Marlin G. E., Kaye C. M., Smith D. M. New approach to assessment of cardioselectivity of beta-blocking drugs. Br Med J. 1974 Nov 23;4(5942):444–447. doi: 10.1136/bmj.4.5942.444. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. MCNEILL R. S. EFFECT OF A BETA-ADRENERGIC-BLOCKING AGENT, PROPRANOLOL, ON ASTHMATICS. Lancet. 1964 Nov 21;2(7369):1101–1102. doi: 10.1016/s0140-6736(64)92617-0. [DOI] [PubMed] [Google Scholar]
  14. Macdonald A. G., McNeill R. S. A comparison of the effect on airway resistance of a new beta blocking drug, ICI.50,172 and propranolol. Br J Anaesth. 1968 Jul;40(7):508–510. doi: 10.1093/bja/40.7.508. [DOI] [PubMed] [Google Scholar]
  15. McDevitt D. G. beta-Adrenoceptor antagonists and respiratory function. Br J Clin Pharmacol. 1978 Feb;5(2):97–99. doi: 10.1111/j.1365-2125.1978.tb01607.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Oh V. M., Kaye C. M., Warrington S. J., Taylor E. A., Wadsworth J. Studies of cardioselectivity and partial agonist activity in beta-adrenoceptor blockade comparing effects on heart rate and peak expiratory flow rate during exercise. Br J Clin Pharmacol. 1978 Feb;5(2):107–120. doi: 10.1111/j.1365-2125.1978.tb01609.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Richardson P. S., Sterling G. M. Effects of beta-adrenergic receptor blockade on airway conductance and lung volume in normal and asthmatic subjects. Br Med J. 1969 Jul 19;3(5663):143–145. doi: 10.1136/bmj.3.5663.143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Shenfield G. M., Paterson J. W. Clinical assessment of bronchodilator drugs delivered by aerosol. Thorax. 1973 Mar;28(2):124–128. doi: 10.1136/thx.28.2.124. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Skinner C., Gaddie J., Palmer K. N. Comparison of effects of metoprolol and propranolol on asthmatic airway obstruction. Br Med J. 1976 Feb 28;1(6008):504–504. doi: 10.1136/bmj.1.6008.504. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Skinner C., Palmer K. N. Changes in specific airways conductance and forced expiratory volume in one second after a bronchodilator in normal subjects and patients with airways obstruction. Thorax. 1974 Sep;29(5):574–577. doi: 10.1136/thx.29.5.574. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Stephen S. A. Unwanted effects of propranolol. Am J Cardiol. 1966 Sep;18(3):463–472. doi: 10.1016/0002-9149(66)90071-3. [DOI] [PubMed] [Google Scholar]
  22. Tattersfield A. E., Leaver D. G., Pride N. B. Effects of beta-adrenergic blockade and stimulation on normal human airways. J Appl Physiol. 1973 Nov;35(5):613–619. doi: 10.1152/jappl.1973.35.5.613. [DOI] [PubMed] [Google Scholar]
  23. Warrell D. A., Robertson D. G., Howes J. N., Conolly M. E., Paterson J. W., Beilin L. J., Dollery C. T. Comparison of cardiorespiratory effects of isoprenaline and salbutamol in patients with bronchial asthma. Br Med J. 1970 Jan 10;1(5688):65–70. [PMC free article] [PubMed] [Google Scholar]
  24. Wasserman M. A., Levy B. Selective beta adrenergic receptor antagonism in the anesthetized dog. J Pharmacol Exp Ther. 1974 Feb;188(2):357–367. [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES